Jingyi Zhang

Dr. Jingyi Zhang

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2025 in IEEE Access
Verified
Journal Article
Open access
JZJingyi Zhang
Jingyi Zhang
SZShishun Zhao
Shishun Zhao
YXYang Xu
Yang Xu
THTao Hu
Tao Hu
Prediction models for disease onset are critical in biomedical research and survival analysis. With machine learning methods increasingly being used to handle survival data with censoring, unbiased transformation theory offers an alternative method for estimating survival tasks in the presence of such censoring, thereby enhancing model accuracy. This study aims to develop a reliable and efficient prediction algorithm that utilizes unbiased transformation to improve machine learning model performance on interval-censored data. Therefore, we present ICBoost, a novel survival algorithm that integrates regression trees and ensemble methods specifically designed for interval-censored data. Unlike right-censored data, where the exact event time is unknown but occurs after a known time point, interval-censored data only provides intervals within which the event occurred. The inherent complexity of interval-censored data poses challenges for accurate survival prediction. To overcome these challenges, we propose a kernel density estimationbased unbiased transformation approach to estimate failure time. Furthermore, we develop a novel ensemble framework that combines XGBoost with censoring unbiased transformation. This framework allows for investigating the relationships between patient survival and covariates, thereby enhancing prediction accuracy and model interpretability.We evaluated the performance of the ICBoost algorithm against existing methods using various real and simulated datasets. Our results showed that ICBoost exhibited superior performance in identifying hidden patterns for survival prediction tasks, particularly in datasets related to Alzheimer’s disease and the emergence of permanent teeth in the medical field. ICBoost outperformed other methods, as evidenced by lower root-mean-square error, mean absolute error, and Brier score values.

25 December 2025 in Entropy
Verified
Journal Article
Open access
PDF file
JZJingyi Zhang
Jingyi Zhang
SZShishun Zhao
Shishun Zhao
DLDongmei Lu
Dongmei Lu
JCJianhua Cheng
Jianhua Cheng
Chronic diseases, particularly those with progressive neurological impairment, present a significant challenge in healthcare due to their impact on millions globally and the limited availability of effective therapies. Addressing this challenge requires innovative approaches, such as leveraging individuals’ genetic features for early intervention and treatment strategies. Due to the irregular intervals of patient visits, clinical data typically appear as censored, necessitating advanced analytical methods. Thus, this study introduces GTsurvival, a novel network architecture that combines graph convolutional networks (GCN) with a neural decision tree, providing promising advancements in disease prediction. GTsurvival utilizes restricted mean survival time (RMST) as pseudo-observations and directly connects them with baseline variables. Through the joint simulation of RMST, GTsurvival can effectively utilize shared information and enhance its predictive ability for patients’ future survival status. Firstly, GTsurvival is introduced to handle complex censored data, emphasizing the crucial role of graphs utilized in GCNs for processing related information among samples. Secondly, the neural decision tree within GTsurvival enhances decision-making by mitigating uncertainty at split nodes, effectively minimizing the global loss function and optimizing survival analysis in high-dimensional datasets. Thirdly, evaluations on simulated datasets and a real-world neurodegenerative disease cohort verify that the proposed GTsurvival method surpasses existing approaches. This superiority is partly attributed to the inclusion of a generalized score test during feature selection, which helps capture variants associated with disease progression.

6 October 2026 in Array
Verified
Journal Article
Open access
JZJingyi Zhang
Jingyi Zhang
SZShishun Zhao
Shishun Zhao
THTao Hu
Tao Hu